Crisugabalin
- Generic Name
- Crisugabalin
- Indication
用于治疗成人糖尿病性周围神经病理性疼痛。
Crisugabalin for Radiotherapy-Related Neuropathic Pain
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-05-18
- Target Recruit Count
- 172
- Registration Number
- NCT06766916
- Locations
- 🇨🇳
Fujian Cancer Hospital, Fuzhou, Fujian, China
🇨🇳Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2023-06-23
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT05916573
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets
Phase 1
- Conditions
- Diabetic NeuropathiesDiabetic Neuropathy Peripheral
- Interventions
- First Posted Date
- 2021-04-12
- Last Posted Date
- 2021-04-12
- Lead Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 22
- Registration Number
- NCT04841720
- Locations
- 🇨🇳
The fourth hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath